Sustained release formulations using non-aqueous carriers
The disclosure relates to a manufactured pre-mixed formulation for injection consisting essentially of a suspension of: (i) a pharmaceutically acceptable non-aqueous carrier which consists essentially of one or more triglycerides of C6-C12 fatty acids; and (ii) microspheres which consist essentially...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The disclosure relates to a manufactured pre-mixed formulation for injection consisting essentially of a suspension of: (i) a pharmaceutically acceptable non-aqueous carrier which consists essentially of one or more triglycerides of C6-C12 fatty acids; and (ii) microspheres which consist essentially of a poly(lactide-co-glycolide) polymer having dispersed therein about 5% (w/w) exenatide as active pharmaceutical ingredient and about 2% (w/w) sucrose; wherein the ratio of lactide:glycolide in the polymer is about 1:1. |
---|